화학공학소재연구정보센터
검색결과 : 8건
No. Article
1 Angiotensin-converting enzyme 2 is a potential therapeutic target for EGFR-mutant lung adenocarcinoma
Yamaguchi M, Hirai S, Sumi T, Tanaka Y, Tada M, Nishii Y, Hasegawa T, Uchida H, Yamada G, Watanabe A, Takahashi H, Sakuma Y
Biochemical and Biophysical Research Communications, 487(3), 613, 2017
2 Combined therapeutic potential of nuclear receptors with receptor tyrosine kinase inhibitors in lung cancer
Wairagu PM, Park KH, Kim J, Choi JW, Kim HW, Yeh BI, Jung SH, Yong SJ, Jeong Y
Biochemical and Biophysical Research Communications, 447(3), 490, 2014
3 Small-Molecule Inhibitors of the Receptor Tyrosine Kinases: Promising Tools for Targeted Cancer Therapies
Hojjat-Farsangi M
International Journal of Molecular Sciences, 15(8), 13768, 2014
4 The Role of Mitochondrial DNA Damage and Repair in the Resistance of BCR/ABL-Expressing Cells to Tyrosine Kinase Inhibitors
Glowacki S, Synowiec E, Blasiak J
International Journal of Molecular Sciences, 14(8), 16348, 2013
5 New platform for controlled and sustained delivery of the EGF receptor tyrosine kinase inhibitor AG1478 using poly(lactic-co-glycolic acid) microspheres
Robinson R, Bertram JP, Reiter JL, Lavik EB
Journal of Microencapsulation, 27(3), 263, 2010
6 A novel perspective on designing the inhibitor of HER2 receptor
Chen CYC
Journal of the Chinese Institute of Chemical Engineers, 39(4), 291, 2008
7 Sunitinib: A VEGF and PDGF receptor protein kinase and angiogenesis inhibitor
Roskoski R
Biochemical and Biophysical Research Communications, 356(2), 323, 2007
8 Eliminating membrane depolarization caused by the Alzheimer peptide A beta(1-42, aggr.)
Blanchard BJ, Stockwell BR, Ingram VM
Biochemical and Biophysical Research Communications, 293(4), 1204, 2002